LEUPRORELIN (PROSTAP 3 DCS ®)

Clinical Indication

Breast cancer

Comments

3 monthly preparation

Date of classification

June 2021

Review date

June 2021

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.